EnGeneIC Company
EnGeneIC develops and commercializes the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Sydney, New South Wales, Australia
Founded Date:
2000
Employees Number:
11-50
Estimated Revenue:
Less than $1M
Register and Claim Ownership